Zhengqing Qiu

498 total citations
40 papers, 273 citations indexed

About

Zhengqing Qiu is a scholar working on Molecular Biology, Physiology and Rheumatology. According to data from OpenAlex, Zhengqing Qiu has authored 40 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Physiology and 14 papers in Rheumatology. Recurrent topics in Zhengqing Qiu's work include Lysosomal Storage Disorders Research (13 papers), Glycogen Storage Diseases and Myoclonus (12 papers) and Biochemical and Molecular Research (6 papers). Zhengqing Qiu is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Glycogen Storage Diseases and Myoclonus (12 papers) and Biochemical and Molecular Research (6 papers). Zhengqing Qiu collaborates with scholars based in China, United States and Brazil. Zhengqing Qiu's co-authors include Min Wei, Fengxia Yao, Huiping Shi, Weimin Zhang, Yan Meng, Shuang Liu, Cheng Shen, Quan Shi, Xiafei Hong and Yi Dai and has published in prestigious journals such as PLoS ONE, Gene and Osteoporosis International.

In The Last Decade

Zhengqing Qiu

36 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengqing Qiu China 10 96 95 78 75 49 40 273
Joanna Taybert Poland 8 72 0.8× 56 0.6× 118 1.5× 111 1.5× 39 0.8× 17 274
Sun Hee Heo South Korea 10 70 0.7× 124 1.3× 138 1.8× 24 0.3× 41 0.8× 24 311
Surekha Pendyal United States 9 121 1.3× 128 1.3× 89 1.1× 214 2.9× 58 1.2× 21 366
Fengxia Yao China 11 94 1.0× 26 0.3× 153 2.0× 21 0.3× 11 0.2× 31 270
Fatma Al‐Jasmi United Arab Emirates 10 77 0.8× 58 0.6× 103 1.3× 21 0.3× 15 0.3× 20 280
Bert Bachrach United States 9 141 1.5× 22 0.2× 67 0.9× 96 1.3× 39 0.8× 13 293
H. Ebrahim United Kingdom 7 34 0.4× 192 2.0× 92 1.2× 38 0.5× 29 0.6× 8 324
Adam M. Lopez United States 11 42 0.4× 126 1.3× 171 2.2× 13 0.2× 32 0.7× 24 339
Veronica Ileana Guerci Italy 7 108 1.1× 109 1.1× 82 1.1× 58 0.8× 39 0.8× 10 288
Han‐Wook Yoo South Korea 10 59 0.6× 79 0.8× 113 1.4× 9 0.1× 18 0.4× 16 253

Countries citing papers authored by Zhengqing Qiu

Since Specialization
Citations

This map shows the geographic impact of Zhengqing Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengqing Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengqing Qiu more than expected).

Fields of papers citing papers by Zhengqing Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengqing Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengqing Qiu. The network helps show where Zhengqing Qiu may publish in the future.

Co-authorship network of co-authors of Zhengqing Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengqing Qiu. A scholar is included among the top collaborators of Zhengqing Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengqing Qiu. Zhengqing Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tingting, et al.. (2025). Development and Validation of an LC–MS/MS Assay for Quantitative Analysis of Nusinersen in Human CSF and Plasma. Biomedical Chromatography. 39(7). e70138–e70138.
3.
Zhong, Linqing, Wei Wang, Xiaoyan Tang, et al.. (2024). Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome. Clinical Rheumatology. 43(3). 1171–1181. 1 indexed citations
4.
Yao, Fengxia, Dan‐Hua Li, Weimin Zhang, et al.. (2024). Long-read sequencing enables comprehensive molecular genetic diagnosis of Fabry disease. Human Genomics. 18(1). 133–133. 3 indexed citations
5.
Wang, Wei, Linqing Zhong, Shan Jian, et al.. (2023). Unique mutation spectrum of progressive pseudorheumatoid dysplasia in the Chinese population: a retrospective genotype–phenotype analysis of 105 patients. World Journal of Pediatrics. 19(7). 674–686. 2 indexed citations
6.
Cheng, Ruoqian, Yanqin Ying, Zhengqing Qiu, et al.. (2022). Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader–Willi syndrome. World Journal of Pediatrics. 19(5). 438–449. 9 indexed citations
7.
Zhou, Yu, et al.. (2021). [Analysis of the clinical perinatal characteristics of 226 patients with Prader-Willi syndrome in China].. PubMed. 59(6). 466–470. 3 indexed citations
8.
Sun, Chengjun, Pei Zhou, Lin Yang, et al.. (2020). Separation in genetic pathogenesis of mutations in FBN1‐TB5 region between autosomal dominant acromelic dysplasia and Marfan syndrome. Birth Defects Research. 112(20). 1834–1842. 3 indexed citations
9.
Zhao, Yuying, Zhaoxia Wang, Jiahong Lu, et al.. (2019). Characteristics of Pompe disease in China: a report from the Pompe registry. Orphanet Journal of Rare Diseases. 14(1). 78–78. 17 indexed citations
10.
Zhang, Jiangwei, et al.. (2017). Clinical and genetic characteristics of 17 Chinese patients with glycogen storage disease type IXa. Gene. 627. 149–156. 17 indexed citations
11.
Lv, Fang, W. F. Mader, Wei Liu, et al.. (2017). A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporosis International. 28(9). 2691–2700. 22 indexed citations
12.
Liu, Shuang, Weimin Zhang, Huiping Shi, et al.. (2016). Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations. PLoS ONE. 11(9). e0163204–e0163204. 12 indexed citations
13.
Liu, Shuang, Xiafei Hong, Cheng Shen, et al.. (2015). Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Medical Genetics. 16(1). 26–26. 26 indexed citations
14.
Wei, Min, et al.. (2014). [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients].. PubMed. 52(12). 896–901. 2 indexed citations
15.
Liu, Shuang, Weimin Zhang, Huiping Shi, Yan Meng, & Zhengqing Qiu. (2013). Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma. Gene. 535(2). 294–298. 13 indexed citations
16.
Wang, Xin‐Cun, Wentao Zhang, Huiping Shi, et al.. (2011). Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis. Clinical Genetics. 81(5). 443–452. 24 indexed citations
17.
Qiu, Zhengqing, et al.. (2011). [Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].. PubMed. 49(3). 203–8. 9 indexed citations
18.
Wang, Xinning, Huiping Shi, Zhengqing Qiu, et al.. (2011). [Mutation analysis and prenatal diagnosis of 2 cases with mucopolysaccharidosis type I].. PubMed. 49(4). 306–10.
19.
Wang, Wei, et al.. (2009). [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].. PubMed. 47(8). 608–12. 1 indexed citations
20.
Qiu, Zhengqing, Min Wei, Ge Liu, & Guoyang Liu. (2003). [Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation].. PubMed. 41(4). 252–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026